Anti-Lactate Dehydrogenase Isoenzyme V 抗体 (ab9002)

ab9002 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab9002 は 20 報の論文で使用されています。

  • Koukourakis MI  et al. Normal tissue radioprotection by amifostine via Warburg-type effects. Sci Rep 6:30986 (2016). WB . PubMed: 27507219
  • Wojtkowiak JW  et al. Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302. Cancer Metab 3:2 (2015). IHC-P ; Mouse . PubMed: 25635223
  • Koukourakis MI  et al. Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy. Br J Cancer 110:2217-23 (2014). WB ; Human . PubMed: 24714743
  • Yu Y  et al. Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment. World J Surg Oncol 12:78 (2014). IHC . PubMed: 24679073
  • Giatromanolaki A  et al. Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas. Hematol Oncol Stem Cell Ther 6:20-5 (2013). PubMed: 23664601
  • Giatromanolaki AN  et al. Autophagy patterns and prognosis in uveal melanomas. Mod Pathol 24:1036-45 (2011). PubMed: 21499230
  • Koukourakis MI  et al. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clin Cancer Res 17:4892-900 (2011). PubMed: 21632858
  • Seth P  et al. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. Neoplasia 13:60-71 (2011). WB ; Human . PubMed: 21245941
  • Rademakers SE  et al. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1a, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer 11:167 (2011). IHC-Fr ; Human . PubMed: 21569415
  • Koukourakis MI  et al. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer 103:1209-14 (2010). IHC-P ; Human . PubMed: 20842118
  • Giatromanolaki A  et al. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol 63:867-72 (2010). PubMed: 20876316
  • Thorn CC  et al. Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype. Gut 58:404-12 (2009). PubMed: 18978174
  • Giatromanolaki A  et al. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis. J Clin Pathol 61:217-20 (2008). PubMed: 17513511
  • Kolev Y  et al. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 15:2336-44 (2008). PubMed: 18521687
  • Steele AJ  et al. p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood 112:3827-34 (2008). WB ; Human . PubMed: 18682598
  • Tsoli E  et al. Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer. J Clin Pathol 60:261-6 (2007). PubMed: 16751302
  • Koukourakis MI  et al. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66:632-7 (2006). PubMed: 16423989
  • Giatromanolaki A  et al. c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Clin Cancer Res 10:7972-7 (2004). PubMed: 15585632
  • Giatromanolaki A  et al. BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res 10:5566-71 (2004). PubMed: 15328198
  • Koukourakis MI  et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89:877-85 (2003). PubMed: 12942121

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録